ID   Calu-3 2B4
AC   CVCL_YZ47
SY   2B4
DR   cancercelllines; CVCL_YZ47
DR   GEO; GSE17400
DR   Wikidata; Q98125608
RX   PubMed=20090954;
CC   Population: Caucasian.
CC   Characteristics: Increased expression of ACE2.
CC   Virology: Highly susceptible to SARS coronavirus (SARS-CoV) infection (PubMed=20090954).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0609 ! Calu-3
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 7
//
RX   PubMed=20090954; DOI=10.1371/journal.pone.0008729;
RA   Yoshikawa T., Hill T.E., Yoshikawa N., Popov V.L., Galindo C.L.,
RA   Garner H.R., Peters C.J., Tseng C.-T.;
RT   "Dynamic innate immune responses of human bronchial epithelial cells
RT   to severe acute respiratory syndrome-associated coronavirus
RT   infection.";
RL   PLoS ONE 5:E8729-E8729(2010).
//